FDA approves generic ciprofloxacin injection

September 7, 2006

The FDA has approved several abbreviated new drug applications for generic versions of ciprofloxacin injection for bacterial infections, including urinary tract infections.

The FDA has approved several abbreviated new drug applications for generic versions of ciprofloxacin injection for bacterial infections, including urinary tract infections.

Ciprofloxacin injection USP, 10 mg/mL, is packaged in 20-mL and 40-mL vials and a 120-mL pharmacy bulk package. The products are manufactured by multiple generic drug companies.